Longitude Capital

Investor type







United States

$0-1 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy


Longitude Capital specializes in making venture growth investments in biotechnology, medical technology and health solutions companies that seek to improve clinical outcomes, enhance quality of life, and/or reduce system costs. We invest in both privately held and publicly traded companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.8 billion across four funds and demonstrated an ability to source, manage, and exit attractive investments across multiple market cycles. Our venture growth strategy is rooted in building a balanced portfolio of clinical-stage and commercial-stage companies with clinically de-risked assets, favorable valuations relative to risk profile, and attractive expected returns within three to five years from initial investment. Longitude Capital seeks to identify new investment opportunities by tapping into our broad network of industry relationships or through the execution of intensive thematic research into emerging therapeutic areas or industry sub-sectors. We utilize a variety of investment structures, including traditional venture capital, asset spin-outs, recapitalizations, PIPEs, open market purchases, royalties, and other equity and equity-linked instruments. Following an initial investment, we work closely with our portfolio companies and syndicate partners to develop and implement strategic plans, achieve key operating objectives, build world-class teams, raise capital, and pursue liquidity opportunities in a manner that optimizes returns to key stakeholders. Our company name was inspired by the Longitude Prize, a competition established by the British monarchy in 1714 to solve one of the greatest scientific problems of the day. Investing in Healthcare Innovation Longitude Capital invests in biotechnology, medical technology, and health solutions companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system cost. From start-ups to growth equity investments, we are dedicated to helping management teams achieve technical, clinical, and commercial milestones to create value and deliver attractive returns to our limited partners. Our Team, Your Partners Longitude Capital’s founders have been investing together since 2002. Our team has over 150 years of combined investing experience in the life sciences industry and has collaborated on over 70 new investments and 150 follow-on investments in the biotechnology, medical technology, and health solutions sectors. We operate from our offices in Menlo Park, California, Greenwich, Connecticut and Boston, Massachusetts.


Fashion/Beauty Healthcare Services Other Telecommunications HealthTech

Region of investment

North America Europe


Upgrade to see contacts
MXGPTmpu1vQnZxBO Managing Director
Managing Director
MXGPTmpu1vQnZxBO Principal
MXGPTmpu1vQnZxBO Summer Analyst
Summer Analyst
MXGPTmpu1vQnZxBO Director Of Human Resources
Director Of Human Resources
MXGPTmpu1vQnZxBO Associate
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!